慢性肺疾病患儿外周血细胞因子的改变

罗英, 唐丽君, 黄为民

中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (11) : 855-857.

PDF(897 KB)
PDF(897 KB)
中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (11) : 855-857.
论著·临床研究

慢性肺疾病患儿外周血细胞因子的改变

  • 罗英,唐丽君,黄为民
作者信息 +

Levels of cytokines in peripheral blood of premature infants with chronic lung disease

  • LUO Ying, TANG Li-Jun, HUANG Wei-Min
Author information +
文章历史 +

摘要

目的:观察早产儿慢性肺疾病外周血白细胞介素(IL)-1β、IL-6、IL-8和肿瘤坏死因子-α(TNF-α)的表达,探讨免疫因素在慢性肺疾病中的可能作用。方法:26例住院满28 d的早产儿分为慢性肺疾病组(14例)和非慢性肺疾病组(对照组,12例),用液相芯片技术(Bio-plex悬浮蛋白芯片系统)检测两组患儿外周血中IL-1β、IL-6、IL-8、TNF-α的表达水平。结果:慢性肺疾病组患儿外周血的IL-1β、IL-6、IL-8、TNF-α与对照组差异均无统计学意义,P>0.05。结论:外周血中的IL-1β、IL-6、IL-8、TNF-α在慢性肺疾病的非急性期没有发生很大的改变,免疫因素可能不在慢性肺疾病的非急性期起作用。[中国当代儿科杂志,2010,12(11):855-857]

Abstract

OBJECTIVE: This study examined the levels of interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor alpha (TNF-α) in peripheral blood of premature infants with chronic lung disease (CLD) in order to investigate the possible role of immunologic factors in CLD. METHODS: Twenty-six premature infants who had been admitted to the neonatal intensive care unit for 28 days were classified into CLD (n=14) and non-CLD (control, n=12) groups. IL-1β, IL-6, IL-8 and TNF-α concentrations in peripheral blood were measured by multiplex technique (Bio-plex). RESULTS: There were no significant differences in peripheral blood levels of IL-1β, IL-6, IL-8 and TNF-α between the two groups. CONCLUSIONS: There are no significant changes in peripheral blood levels of IL-1β, IL-6, IL-8 and TNF-α in premature infants with CLD on the non-acute phase. Immunologic factors might not play a key role in CLD on the phase.[Chin J Contemp Pediatr, 2010, 12 (11):855-857]

关键词

白细胞介素 / 肿瘤坏死因子 / 慢性肺疾病 / 早产儿

Key words

Interleukin / Tumor necrosis factor / Chronic lung disease / Premature infant

引用本文

导出引用
罗英, 唐丽君, 黄为民. 慢性肺疾病患儿外周血细胞因子的改变[J]. 中国当代儿科杂志. 2010, 12(11): 855-857
LUO Ying, TANG Li-Jun, HUANG Wei-Min. Levels of cytokines in peripheral blood of premature infants with chronic lung disease[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(11): 855-857
中图分类号: R563   

参考文献

[1]Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate[J]. Arch Dis Child Fetal Neonatal Ed, 2008, 93(6): F455-F461.
 [2]Merritt TA, Deming DD, Boynton BR. The 'new' bronchopulmonary dysplasia: challenges and commentary[J]. Semin Fetal Neonatal Med, 2009, 14(6):345-357.
  [3]Cayabyab RG, Jones CA, Kwong KY, Hendershott C, Lecart C, Minoo P, et al. Interleukin-1beta in the bronchoalveolar lavage fluid of premature neonates: a marker for maternal chorioamnionitis and predictor of adverse neonatal outcome[J]. Matern Fetal Neonatal Med, 2003, 14(3): 205-211.
[4]Kunzmann S, Speer CP, Jobe AH, Kramer BW. Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs[J].Am J Physiol Lung Cell Mol Physiol, 2007, 292(1): 223-231.
[5]Truog WE, Ballard PL, Norberg M, Golombek S, Savani RC, Merrill JD, et al. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide[J]. Pediatrics, 2007, 119(4): 670-678.
[6]De Dooy J, Ieven M, Stevens W, De Clerck L, Mahieu L. High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation[J]. Pediatr Pulmonol, 2007, 42(3): 193-203.
[7]Vento G, Matassa PG, Ameglio F, Capoluongo E, Zecca E, Tortorolo L, et al. HFOV in premature neonates:effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial[J]. Intensive Care Med, 2005, 31(3): 463-470.
 [8]Von der Hardt K, Kandler MA, Fink L, Schoof E, D-tsch J, Brandenstein O, et al. High frequency oscillatory ventilation suppresses inflammatory response in lung tissue and microdissected alveolar macrophages in surfactant depleted piglets[J]. Pediatr Res, 2004, 55(2): 339-346.
[9]Jónsson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants[J]. Arch Dis Child Fetal Neonatal Ed, 1997, 77(3): 198-201.
[10]Kazzi SN, Romero R, McLaughlin K, Ager J, Janisse J. Serial changes in levels of IL6 and IL-1beta in premature infants at risk for bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 2001, 31(3): 220-226.
[11]Van Marter LJ.Epidemiology of bronchopulmonary dysplasia[J]. Semin Fetal Neonatal Med, 2009, 14(6): 358-366.
[12]Deakins KM.Bronchopulmonary dysplasia[J]. Respir Care, 2009, 54(9): 1252-1262.
[13]Patterson AM, Taciak V, Lovchik J, Fox RE, Campbell AB, Viscardi RM. Ureaplasma urealyticum respiratory tract clonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants[J]. Pediatr Infect Dis J, 1998, 17(4): 321-328.
[14]An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, et al. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptorⅠ in the cord blood as predictors of chronic lung disease in premature infants[J]. Am J Obsret Gynecol, 2004, 191(5): 1649-1654.
[15]Mahieu LM, De Dooy JJ, leven MM, Bridts CH, Stevens WJ. Increased levels of tumor necrosis factor-alpha and decreased levels of interleukin-12 p70 in tracheal aspirates, within 2 hrs after birth, are associated with mortality among ventilated preterm infants[J]. Pediatr Crit Cara Med, 2005, 6(6): 682-689.
[16]Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchpulmonary dysplasia[J].Eur J Pediatr, 1996, 155(2): 112-116.
[17]富建华.细胞因子在早产儿慢性肺疾病发生中的作用[J].中国当代儿科杂志,2003, 5(5):488-491.
[18]Capoluongo E, Vento G, Santonocito C, Matassa PG, Vaccarella C, Giardina B, et al. Comparison of serum levels of seven cytokines in premature newborns undergoing different ventilatory procedures: high frequency oscillatory ventilation or synchronized intermittent mandatory ventilation[J]. Eur Cytokine Netw, 2005, 16 (3): 199-205.
[19]Thompson A, Bhandari V. Pulmonary biomarkers of bronchopulmonary dysplasia[J]. Biomark Insights, 2008, 3: 361-373.


PDF(897 KB)

Accesses

Citation

Detail

段落导航
相关文章

/